Basic Information
| LncRNA/CircRNA Name | MAPT-AS1 |
| Synonyms | NA |
| Region | GRCh38_17:45799390-45895630 |
| Ensemble | ENSG00000264589 |
| Refseq | NR_024559 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | breast cancer |
| ICD-0-3 | C50 |
| Methods | qPCR |
| Sample | breast cancer tissues |
| Expression Pattern | up-regulated |
| Function Description | we found that MAPT-AS1 is overexpressed in breast cancer but not in triple negative breast cancer (TNBC), and that high expression of MAPT-AS1 was correlated with better patient survival. |
| Pubmed ID | 30074401 |
| Year | 2018 |
| Title | Overexpression of MAPT-AS1 Is Associated With Better Patient Survival in Breast Cancer. |
External Links
| Links for MAPT-AS1 | GenBank HGNC NONCODE |
| Links for breast cancer | OMIM COSMIC |